Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert

Seeking Alpha

Synta Pharmaceuticals Inc. (SNTA)

()

News & PR
Market Currents

Buzz
Twitter: SNTA

Business Intelligence
Transcripts1 new
Events
Key Developments


	52wk high:
	52wk low:
	EPS:
	PE:
	Dividend:
	Yield:
	Market Cap:
	Exchange:

Analysis - Latest Articles

Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers

Justin M. Hall • Sep 20 • 3 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up

Justin M. Hall • Sep 11 • 23 Comments
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly

Mark Cifra • Apr 02 • 5 Comments
Morphosys: A Biotech Rule Breaker (Part 2)

Ohad Hammer • Mar 30 • Comment!
Chink in the Biotechnology Armor

Michael Becker • Mar 01 • 4 Comments
Friday's Options Recap

Frederic Ruffy • Feb 13 • 1 Comment

More articles on SNTA »

Latest Transcript

Synta Pharmaceuticals Corp. Q3 2009 Earnings Call Transcript

Wed November 4, 2009

More transcripts on SNTA »

Instablogs

Spectrum Pharmaceuticals: $50 Million Vote of Confidence or Cause for Concern

Fri September 18, 2009 • Justin M. Hall • 15 Comments
Spectrum Pharmaceuticals: Post Zevalin Approval Sales Should Ramp Up

Fri September 11, 2009 • Justin M. Hall • 10 Comments

Write a post on SNTA | More Instablogs on SNTA »

Sentiment

What advice would you give to
SNTA?

What's your view of SNTA?

Make sure you include SNTA